Characterization of Δ7/11, a functional prolactin-binding protein

Journal of Molecular Endocrinology

Volumn 50, Issue 1, 2013, Pages 79-90

  Fleming, J M ^a,c   Ginsburg, E ^a   McAndrew, C W ^b   Heger, C D ^b   Cheston, L ^c   Rodriguez Canales, J ^b   Vonderhaar, B K ^a   Goldsmith, P ^b  

^a Bldg 10   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

Alternative splicing; Mammary; Prolactin; Prolactin receptor; Prolactin binding protein

Indexed keywords

PROLACTIN; PROLACTIN BINDING PROTEIN DELTA 7/11; PROLACTIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST BIOPSY; BREAST EPITHELIUM; BREAST TUMOR; CELL AGING; CELL CYCLE ARREST; CELL PROLIFERATION; CELLULAR DISTRIBUTION; FEMALE; GLYCOSYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RNA SPLICING; SIGNAL TRANSDUCTION;

ANIMALS; BIOPSY; BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; GLYCOSYLATION; HUMANS; IMMUNOPRECIPITATION; MILK, HUMAN; POLYMERASE CHAIN REACTION; PROLACTIN; PROTEIN BINDING; RECOMBINANT PROTEINS;

EID: 84872023018     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0201     Document Type: Article

References (39)

1. Banerjee R, Ginsburg E & Vonderhaar BK 1993 Characterization of a monoclonal antibody against human prolactin receptors. International Journal of Cancer 55 712-721. (doi:10.1002/ijc.2910550503)
2. Bentzien F, Struman I, Martini JF, Martial J & Weiner R 2001 Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(K/K) mice. Cancer Research 61 7356-7362.
3. Bernichtein S, Touraine P & Goffin V 2010 New concepts in prolactin biology. Journal of Endocrinology 206 1-11. (doi:10.1677/JOE-10-0069)
4. Bole-Feysot C, Goffin V, Edery M, Binart N & Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews 19 225-268. (doi:10.1210/er.19.3.225)
5. Brisken C & O'Malley B 2010 Hormone action in the mammary gland. Cold Spring Harbor Perspectives in Biology 2 a003178. (doi:10.1101/cshper-spect.a003178)
6. Buteau H, Pezet A, Ferrag F, Perrot-Applanat M, Kelly PA & Edery M 1998 N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting. Molecular Endocrinology 12 544-555. (doi:10.1210/me.12.4.544)
7. Cahoreau C, Garnier L, Djiane J, Devauchelle G & Cerutti M 1994 Evidence for N-glycosylation and ubiquitination of the prolactin receptor expressed in a baculovirus-insect cell system. FEBS Letters 350 230-234. (doi:10.1016/0014-5793(94)00772-1)
8. Clapp C, Gonzalez C, Macotela Y, Aranda J, Rivera JC, Garcia C, Guzman J, Zamorano M, Vega C, Martin C et al. 2006 Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function. Frontiers of Hormone Research 35 64-73.
9. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT & Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. American Journal of Pathology 146 695-705.
10. Clevenger CV, Gadd SL & Zheng J 2009 New mechanisms for PRLr action in breast cancer. Trends in Endocrinology and Metabolism 20 223-229. (doi:10.1016/j.tem.2009.03.001)
11. Dannies PS 2001 A serum prolactin-binding protein: implications for growth hormone. Trends in Endocrinology and Metabolism 12 427-428. (doi:10.1016/S1043-2760(01)00497-0)
12. Das R & Vonderhaar BK 1996 Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Research and Treatment 40 141-149. (doi:10.1007/BF01806209)
13. Das R & Vonderhaar BK 1997 Prolactin as a mitogen in mammary cells. Journal of Mammary Gland Biology and Neoplasia 2 29-39. (doi:10.1023/A:1026369412612)
14. Fonseca ME, Ochoa R, Moran C & Zarate A 1991 Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation. Journal of Endocrinological Investigation 14 907-912.
15. Ginsburg E & Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Research 55 2591-2595.
16. Harris J, Stanford PM, Oakes SR & Ormandy CJ 2004 Prolactin and the prolactin receptor: new targets of an old hormone. Annals of Medicine 36 414-425. (doi:10.1080/07853890410033892)
17. Hennighausen L, Robinson GW, Wagner KU & Liu W 1997 Prolactin signaling in mammary gland development. Journal of Biological Chemistry 272 7567-7569. (doi:10.1074/jbc.272.12.7567)
18. Hovey RC, Trott JF & Vonderhaar BK 2002 Establishing a framework for the functional mammary gland: from endocrinology to morphology. Journal of Mammary Gland Biology and Neoplasia 7 17-38. (doi:10.1023/A:1015766322258)
19. Katz E & Streuli CH 2007 The extracellular matrix as an adhesion checkpoint for mammary epithelial function. International Journal of Biochemistry and Cell Biology 39 715-726. (doi:10.1016/j.biocel.2006.11.004)
20. Kim J, Luo W, Chen DT, Earley K, Tunstead J, Yu-Lee LY & Lin SH 2003 Antitumor activity of the 16-kDa prolactin fragment in prostate cancer. Cancer Research 63 386-393.
21. Kline JB & Clevenger CV 2001 Identification and characterization of the prolactin-binding protein in human serum and milk. Journal of Biological Chemistry 276 24760-24766. (doi:10.1074/jbc.M011786200)
22. Kline JB, Rycyzyn MA & Clevenger CV 2002 Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain. Molecular Endocrinology 16 2310-2322. (doi:10.1210/me.2001-0033)
23. LaPensee EW & Ben-Jonathan N 2010 Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy. Endocrine-Related Cancer 17 R91-R107. (doi:10.1677/ERC-09-0253)
24. Nguyen NQ, Cornet A, Blacher S, Tabruyn SP, Foidart JM, Noel A, Martial JA & Struman I 2007 Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL. Molecular Therapy 15 2094-2100. (doi:10.1038/sj.mt.6300294)
25. Nguyen N, Stellwag EJ & Zhu Y 2008 Prolactin-dependent modulation of organogenesis in the vertebrate: recent discoveries in zebrafish. Comparative Biochemistry and Physiology C Toxicology & Pharmacology 148 370-380. (doi:10.1016/j.cbpc.2008.05.010)
26. Oakes SR, Rogers RL, Naylor MJ & Ormandy CJ 2008 Prolactin regulation of mammary gland development. Journal of Mammary Gland Biology and Neoplasia 13 13-28. (doi:10.1007/s10911-008-9069-5)
27. Perks CM, Keith AJ, Goodhew KL, Savage PB, Winters ZE & Holly JM 2004 Prolactin acts as a potent survival factor for human breast cancer cell lines. British Journal of Cancer 91 305-311.
28. Piwnica D, Touraine P, Struman I, Tabruyn S, Bolbach G, Clapp C, Martial JA, Kelly PA & Goffin V 2004 Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. Molecular Endocrinology 18 2522-2542. (doi:10.1210/me.2004-0200)
29. Prince JM, Klinowska TC, Marshman E, Lowe ET, Mayer U, Miner J, Aberdam D, Vestweber D, Gusterson B & Streuli CH 2002 Cell-matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Developmental Dynamics 223 497-516. (doi:10.1002/dvdy.10070)
30. Rooney N & Streuli CH 2011 How integrins control mammary epithelial differentiation: a possible role for the ILK-PINCH-Parvin complex. FEBS Letters 585 1663-1672. (doi:10.1016/j.febslet.2011.05.014)
31. Rose-John S & Heinrich PC 1994 Soluble receptors for cytokines and growth factors: generation and biological function. Biochemical Journal 300 281-290.
32. Schedin P & Keely PJ 2011 Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harbor Perspectives in Biology 3 a003228. (doi:10.1101/cshperspect.a003228)
33. Shaw-Bruha CM, Pirrucello SJ & Shull JD 1997 Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing. Breast Cancer Research and Treatment 44 243-253. (doi:10.1023/A:1005879103367)
34. Trott JF, Hovey RC, Koduri S & Vonderhaar BK 2003 Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. Journal of Molecular Endocrinology 30 31-47. (doi:10.1677/jme.0.0300031)
35. Trott JF, Hovey RC, Koduri S & Vonderhaar BK 2004 Multiple new isoforms of the human prolactin receptor gene. Advances in Experimental Medicine and Biology 554 495-499.
36. Trott JF, Vonderhaar BK & Hovey RC 2008 Historical perspectives of prolactin and growth hormone as mammogens, lactogens and galactagogues - agog for the future!. Journal of Mammary Gland Biology and Neoplasia 13 3-11. (doi:10.1007/s10911-008-9064-x)
37. Vonderhaar BK 1999 Prolactin involvement in breast cancer. Endocrine-Related Cancer 6 389-404. (doi:10.1677/erc.0.0060389)
38. Vonderhaar BK & Ziska SE 1989 Hormonal regulation of milk protein gene expression. Annual Review of Physiology 51 641-652. (doi:10.1146/annurev.ph.51.030189.003233)
39. Vonderhaar BK, Bhattacharya A, Alhadi T, Liscia DS, Andrew EM, Young JK, Ginsburg E, Bhattacharjee M & Horn TM 1985 Isolation, characterization, and regulation of the prolactin receptor. Journal of Dairy Science 68 466-488. (doi:10.3168/jds.S0022-0302(85)80847-X)